Bavarian - I may be wrong, but my understanding is that: 1. The length of recruitment time for the some of the IMU trials has been long primarily because the trials have involved people who have failed various prior lines of treatment. By definition, there are less of them. 2. An Azer cel P2 trial may seek to take people and be open to those who have failed fewer prior lines of treatment - which would get more people, more quickly and be more comparable with 'standard of care'.
However, that's just my understanding and I may be wrong on either or both those points.
IMU Price at posting:
3.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)